For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...

Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could ...

CVS Health is expected to release its fiscal second-quarter earnings later this month, and analysts project a double-digit profit drop.

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Agenus (AGEN) is a stock that can certainly grab the attention ...

RTH benefits from projected retail market growth, with key holdings positioned to capture both essential and discretionary ...

There are many ways companies can manipulate their reported profits. Fudging sales (also known as revenue) is more difficult.

Kathmere Capital Management LLC has recently invested $269,000 in CVS Health Corporation, securing a new position with 3,967 ...

The offering, the first IPO this year, attracted more than 32 billion dirhams ($3.5 bln) in demand for 500 million dirhams in shares. GSK seeks FDA nod for expanded use of RSV vaccine in adults ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen ...

Mutual of America Capital Management trimmed its CVS Health stake by 2.7% in Q1, now worth nearly $9.96 million. Several ...

Johnson & Johnson boosted its full-year outlook as it posted better-than-expected profit and sales in the second quarter. The chip-making equipment supplier, whose clients include Intel, issued a ...

Including the $706 million she disposed of in the first quarter, Safra Catz’s $2.5 billion total makes her the top insider ...